Abstract:Pluripotency, a characteristic of cells in the inner cell mass of the mammalian preimplantation blastocyst as well as of embryonic stem cells, is defined as the ability of a cell to generate all of the cell types of an organism. A group of transcription factors is essential for the establishment and maintenance of the pluripotent state. Recent studies have demonstrated that differentiated somatic cells could be reverted to a pluripotent state by the overexpression of a set of transcription factors, further highlighting the significance of transcription factors in the control of pluripotency. Among these factors, a member of the POU transcription factor family, Oct4, is central to the machinery governing pluripotency. Oct4 is highly expressed in pluripotent cells and becomes silenced upon differentiation. Interestingly, the precise expression level of Oct4 determines the fate of embryonic stem cells. Therefore, to control the expression of Oct4 precisely, a variety of regulators function at multiple levels, including transcription, translation of mRNA and post-translational modification. Additionally, in cooperation with Sox2, Nanog and other members of the core transcriptional regulatory circuitry, Oct4 activates both protein-coding genes and noncoding RNAs necessary for pluripotency. Simultaneously, in association with transcriptional repressive complexes, Oct4 represses another set of targets involved in developmental processes. Importantly, Oct4 can re-establish pluripotency in somatic cells, and proper reprogramming of Oct4 expression is indispensable for deriving genuine induced pluripotent stem cell lines. In the past several years, genome-wide identification of Oct4 target genes and Oct4-centered protein interactomes has been reported, indicating that Oct4 exerts tight control over pluripotency regulator expression and protects embryonic stem cells in an undifferentiated state. Nevertheless, further investigation is required to fully elucidate the underlying molecular mechanisms through which Oct4 maintains and reinitiates pluripotency. Systemic and dynamic exploration of the protein complexes and target genes associated with Oct4 will help to elucidate the role of Oct4 more comprehensively.

Foxm1 Transcription Factor is Required for Maintenance of Pluripotency of P19 Embryonal Carcinoma Cells

Increased levels of FoxA1 transcription factor in pluripotent P19 embryonal carcinoma cells stimulate neural differentiation.

Foxa1 contributes to the repression of Nanog expression by recruiting Grg3 during the differentiation of pluripotent P19 embryonal carcinoma cells.

The Mir-134 Attenuates the Expression of Transcription Factor FOXM1 During Pluripotent NT2/D1 Embryonal Carcinoma Cell Differentiation

Stable Expression of FoxA1 Promotes Pluripotent P19 Embryonal Carcinoma Cells to Be Neural Stem-Like Cells.

Foxm1 Mediates LIF/Stat3-Dependent Self-Renewal in Mouse Embryonic Stem Cells and is Essential for the Generation of Induced Pluripotent Stem Cells

Foxo3a Contributes to the Reprogramming Process and the Differentiation of Induced Pluripotent Stem Cells

Foxd3 suppresses NFAT-mediated differentiation to maintain self-renewal of embryonic stem cells.

The Transcription Factor Foxm1 is Essential for the Quiescence and Maintenance of Hematopoietic Stem Cells

Molecular Mechanism of Cardiac Differentiation in P19 Embryonal Carcinoma Cells Regulated by Foxa2

Forkhead Box Family Transcription Factors As Versatile Regulators for Cellular Reprogramming to Pluripotency.

FOXC1 Downregulates Nanog Expression by Recruiting HDAC2 to Its Promoter in F9 Cells Treated by Retinoic Acid.

Role of Oct4 in Maintaining and Regaining Stem Cell Pluripotency

FoxO transcription factors actuate the formative pluripotency specific gene expression programme

Nspc1 Regulates the Key Pluripotent Oct4–Nanog–Sox2 Axis in P19 Embryonal Carcinoma Cells Via Directly Activating Oct4

FOXD3 controls pluripotency through modulating enhancer activity.

The Transcription Factor TFCP2L1 Induces Expression of Distinct Target Genes and Promotes Self-Renewal of Mouse and Human Embryonic Stem Cells.

Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells

Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells

Foxp1 is Critical for the Maintenance of Regulatory T-cell Homeostasis and Suppressive Function.